K

Kestra Medical Technologies Inc
NASDAQ:KMTS

Watchlist Manager
Kestra Medical Technologies Inc
NASDAQ:KMTS
Watchlist
Price: 24.83 USD -1.51% Market Closed
Market Cap: $1.4B

Net Margin

-186.9%
Current
Improving
by 8.5%
vs 3-y average of -195.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-186.9%
=
Net Income
$-138.8m
/
Revenue
$74.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-186.9%
=
Net Income
$-138.8m
/
Revenue
$74.3m

Peer Comparison

Country Company Market Cap Net
Margin
US
Kestra Medical Technologies Inc
NASDAQ:KMTS
1.4B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
190.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...

Market Distribution

Lower than 88% of companies in the United States of America
Percentile
12th
Based on 15 072 companies
12th percentile
-186.9%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Kestra Medical Technologies Inc
Glance View

Market Cap
1.4B USD
Industry
Health Care

Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington. The company went IPO on 2025-03-06. The firm is focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. The company has developed and commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform include the ASSURE WCD, a next generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient’s heart to normal rhythm. In addition to the ASSURE WCD, its Cardiac Recovery System platform includes a comprehensive suite of fully integrated digital solutions and services.

KMTS Intrinsic Value
6.58 USD
Overvaluation 73%
Intrinsic Value
Price
K
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-186.9%
=
Net Income
$-138.8m
/
Revenue
$74.3m
What is Kestra Medical Technologies Inc's current Net Margin?

The current Net Margin for Kestra Medical Technologies Inc is -186.9%, which is above its 3-year median of -195.4%.

How has Net Margin changed over time?

Over the last 1 years, Kestra Medical Technologies Inc’s Net Margin has increased from -203.5% to -186.9%. During this period, it reached a low of -210.9% on Apr 30, 2025 and a high of -180.6% on Jan 31, 2025.

Back to Top